AntiTrust Health (NYT: FCC, USDOJ) Kaiser and NYMC/Yale
Kathleen
lPick...@cdc.gov, Durlan...@yale.edu, Aa...@columbia.edu,
gary_w...@nymc.edu, scientifi...@ostp.gov,
pkru...@princeton.edu, Stanle...@fiu.edu,
margaret...@hhs.fds.gov, emcsw...@niaid.nih.gov,
afa...@niaid.nih.gov, Spin...@yahoogroups.com, kshe...@calea.org,
fit...@gmail.com, patrick.f...@usdoj.gov,
model...@sbcglobal.net, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, michae...@ct.gov, con...@po.state.ct.us,
executiv...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@ct.gov, kur...@washpost.com, georg...@washpost.com,
p...@allegorypress.com, commissi...@po.state.ct.us,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@ct.gov,
randall...@usdoj.gov, Robert....@yale.edu, editor@greenwich-
post.com, harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, saint....@sbcglobal.net, rre...@berkeley.edu,
pcal...@tribune.com
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, bmi...@newstimes.com, tr...@hotmail.com,
rast...@aol.com, billc...@gmail.com, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com
Subject: AntiTrust Health (NYT: FCC, USDOJ) Kaiser and NYMC/Yale
Date: Feb 9, 2011 4:46 AM
HEALTHCARE RICO ARRANGEMENTS, NYT, BELOW
http://www.nytimes.com/2011/02/09/health/policy/09health.html?hpw
===========================================
Yes. That's exactly what happened
with the American Lyme Disease Foundation
(ALDF.com) started at NYMC by Gary Wormser,
Durland Fish, Edward McSweegan and John J.
Connolly:
http://www.actionlyme.org/CRYME_DISEASE.htm
Kaiser literally TRAINING MDs at NYMC:
http://xnet.kp.org/permanentejournal/spring98pj/strategy.html
The RICO gang, self-expose the "Entrepreneurial
Trio" (which is actually a quartet):
http://www.actionlyme.org/CONNOLLY_FISH_WEINSTEIN.htm
Crazy Eddie McSweegan and Durland Fish conspiring
over the "treatment upon tick attachment" report
in the Plain Old Regular Lyme Disease Foundation's
journal:
http://www.actionlyme.org/Dissem_after_6_hr_attachment.htm
This is the ^^^article over which Durland Fish
flipped and ordered McSweegan to stalk and harass
the Forschners. It doesn't take 48 hours for Lyme to
transmit:
http://www.actionlyme.org/TICK_BITE_CONSPIRACY.htm
Durland Fish ^^^ conspires with Eddie McSweegan to
stalk, wiretap, harass the Lyme Foundation.
Then came the lawsuits for that criminal
behavior on the part of Crazy Eddie:
http://www.actionlyme.org/McSweegan_Relentless.htm
http://www.actionlyme.org/McSweegan.htm
(Stalking and ^^^ harassing several people)
Here you can see that people/humans need to be
treated upon tick attachment and BEFORE
the rash shows up:
http://www.actionlyme.org/Dattwyler_Luft_Bb_DNA_in_CSF.htm
because according ^^^ to Luft, Dattwyler and
Benach, "in 2/3rds of the people, by the
time the rash shows up, spirochetes have
already permanently invaded the brain":
http://www.actionlyme.org/EARLY_CNS_INVASION.htm
http://www.ncbi.nlm.nih.gov/pubmed/2345299
http://www.actionlyme.org/BRAIN_PERMANENT.htm
http://www.actionlyme.org/RICOCHRON.htm
So, Durland Fish and Crazy Eddie of the
Kaiser-Permanente/Israeli Monopoly Investor
ALDF gang did not want it known that people
should be treated upon tick attachment because
that would affect the OspA vaccines trials
protocols:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
If people were treated upon tick attachment
the crooks, during their OspA trials, would not
be able to claim whether or not the vaccine
or the antibiotics prevented Lyme.
I will repeat that, so it's clear what death
crime they committed:
Since it was known that spirochetes go
directly to the brain if they contain
OspC (band 23, left out of Quest's and Smith-
Kline's strain B31):
http://www.ncbi.nlm.nih.gov/pubmed/9234797
"These findings indicate that a function of the Vsp-OspC family of
proteins of Borrelia spp. may be differential localization in organs,
including the brain, during infection."
And the Fish-McSweegan RICO gang committed
their crimes ***for an intended monopoly on
free grant money instead of Venture Cap***:
http://www.actionlyme.org/GOLDWATER_LETTER.htm
(as you can see from ^^^ McSweegan's letter to
Senator Goldwater), starting with an OspA
vaccine and a monopoly, later, a RICO on all
the national blood - not just testing - they
wanted the blood for the infections and human
DNA data:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
(See Schoen, Persing, and Steere:
http://www.actionlyme.org/CORIXARICO.htm
*** They needed OspA as a vaccine, in order
to falsely claim they were entitled to
be the only labs in America performing
testing because, as was their intention,
theirs were the only labs licensed to be
able to test everyone in a post-OspA-LYMErix
era. ***
Corixa/Persing/Schoen claimed that OspA
resulted in chronic Lyme-like illness
("multisystem complaints characteristic
of later forms of the disease" - as shown
and linked here:
http://www.actionlyme.org/CORIXARICO.htm
)
and that they were the only labs (Imugen
and Yale's L2 Diagnostics) in America
able to test everyone in a post-LYMErix
world:
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
Note that according to Persing and Schoen
when they developed the RICO monopoly test:
http://www.actionlyme.org/CORIXARICO.htm
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804
"Thus, the method of the invention is particularly appropriate for
large scale screening or diagnostic applications where only part of
the subject population has been vaccinated or where the vaccination
status of the population is unknown."
and
"vaccinated patients with multisystem complaints characteristic of
later presentations of Lyme disease may be difficult to distinguish
from patients with vaccine failure"
When Schoen and Persing were developing
the RICO Monopoly test (Patent 6,045,804)
they CLAIMED that "MULTI-SYSTEM COMPLAINTS
WERE CHARACTERISTIC OF LATE LYME DISEASE AND
LYMERIX VACCINATION," but in 1998, when planning
how to handle these people who got Chronic Lyme
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
from vaccination (because Chronic Lyme is actually
this:
http://www.actionlyme.org/101016.htm
activated ^^^ Epstein-Barr, Tolerance to
fungal infections in the blood or Chronic
Fatigue Syndrome, in addition to chronic
spirochetes)
Yale's Robert Schoen reported that this
was how MDs should treat those vaccine-injured
and Chronic Lyme victims:
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
"BLOW THEM OFF, OR SEND THEM TO US,
THE RICO LABS, THE ONES WHO TEST FOR
LYME WITH SPIROCHETES WITH NO OSPA/B PLASMID
IN THEM":
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804
As you can see, ^^^ that's the main claim of
the RICO-Blood-Monopoly patent:
"You have to use a strain of Borrelia that
does not have the OspA/B plasmid in it.
(OspA and B are encoded on the same plasmid)
because otherwise, you have UNREADABLE
WESTERN BLOTS:
http://www.actionlyme.org/HOW_RICO_WILL_BE_CHARGED.htm
They later claimed that they can't read their Western Blots
in OspA vaccinated people.
Which was why they, OspA and OspB were left out of
the current Dearborn CDC standard, by Allen Steere
playing strains-games in Europe:
http://www.actionlyme.org/STEERE_IN_EUROPE.htm
(That's a huge ^^^ scientific fraud crime
in and of itself.)
So: How then did the crooks conclude OspA
prevented Lyme if their blots were unreadable?
It didn't. They just LIED about those
results:
http://www.actionyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
CRIMES CONCLUSION:
1) Spirochetes invade the brain early after
tick attachment and permanently.
2) The ALDF.com gang stalked and harassed
the Forschners and others, illegally.
3) OspA was never proven to prevent Lyme.
4) The crooks knew OspA vaccination resulted
in a "multisystem Chronic Lyme-like illness".
5) The Western Blots were unreadable in both
OspA vaccines trials (LYMErix and ImmuLyme)
so both teams like to the FDA and NIH.
6) Steere left OspA and B out of the (current)
diagnostic standard and falsified the science in
order to set up a monopoly for himself and his
business partners (Imugen, in particular).
7) Kaiser-Permanente took over New York Medical
College and *currently* write physician training
protocols.
8) OspA was the key to nearly all diseases:
http://www.actionlyme.org/101016.htm
and inhibited discovery in ALS, HIV, MS
http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm
Cancer, Lupus, etc, etc.
Now we know that it is true that these
weird fungal antigens cannot be vaccines and
this criminal gang ruined medical research for
the West and set us back at least 15 years.
Their overall agenda was this:
http://www.actionlyme.org/CRYME_DISEASE.htm
"No one is allowed to have any illness signs nor is treatment to be
paid for, until the alleged "vaccine" is ready, and then everyone will
be notified about how serious that particular vector borne disease is,
and that they better get the 'vaccine.'"
Now we have the model for a healthcare
RICO: Spinning diseases to suit the DNA
owners-and-the-insurance companies' bottom
line.
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
Seven Plus years ago I reported it simply and
graphically to the USDOJ.
The insurance companies are actively
involved in manipulating the science.
'Helps to have stupid scientists around,
like Crazy Eddie McSweegan and Durland
Fish, who never really were lab scientists:
http://www.actionlyme.org/TICK_BITE_CONSPIRACY.htm
"Want to send her a bogus article?"
"I need more than rumors to attack."
"We did lose the railroad case...." --
Wrote Durland Fish, the crooked restaurant
inspector:
http://groups.google.com/group/scilyme2/browse_thread/thread/f25b0c432bddbb3b/a7826a32d982af9d?hl=en&lnk=gst&q=hilarious+courant+interview#a7826a32d982af9d
http://groups.google.com/group/scilyme2/msg/a7826a32d982af9d?hl=en&dmode=source
"This guy ..." Fish begins. "He cheated. He fabricated an article
in the New England Journal of Medicine. He provided false results. The
paper had to be retracted. He was banned from [National Institutes of
Health] funding for a period of time. The guy used to be the director
of some penile enlargement clinic out on the West Coast. I mean, this
guy ... There's some problems with him."
He proceeds down the list, name by name: "Totally bogus." "He killed
one of his patients." "They tried to shut him down." Words like
"crackpot," "wacko," "buffoon" and "fraud" pepper his discourse.
"A little later, he stops to ponder a question.
"I don't know," he says after a moment's thought. "I don't
know why they hate me so much."
--- Says Hit-List-Fish and his Henchman, Sweeg:
http://www.actionlyme.org/GOLDWATER_LETTER.htm
KMDickson
http://www.actionlyme.org
http://www.relapsingfever.org
===============================================
http://www.nytimes.com/2011/02/09/health/policy/09health.html?hpw
February 8, 2011
Health Law Provision Raises Antitrust Concerns
By ROBERT PEAR
WASHINGTON — The new health care law encourages collaboration by
doctors and hospitals for cost savings, but a split has developed here
as to just how far they can go without running afoul of antitrust
laws.
An influential Republican member of the Federal Trade Commission, J.
Thomas Rosch, said that without “vigorous antitrust enforcement,” the
new alliances of health care providers could reduce competition and
increase costs to consumers.
Mr. Rosch set forth his concerns in private letters to the White House
and the federal Medicare agency. The letters, obtained by The New York
Times, reveal a struggle between the Justice Department and the
commission over who should police the market.
The internal debate creates uncertainty about antitrust enforcement
policy at a moment when scores of hospitals, clinics and doctor groups
are eager to band together and test innovative ways of delivering
care. That uncertainty threatens to slow collaboration by health care
providers. President Obama and other proponents say such cooperation
could cut costs and improve care for millions of people.
When competitors collaborate, economists say, they can produce
enormous efficiencies, but they may also be tempted to engage in
monopolistic practices. The risk tends to be greatest in small- and
medium-size communities dominated by one or two hospitals or health
care systems, experts say.
David A. Balto, a private antitrust lawyer with close ties to the
Obama administration, said the disagreement between the Justice
Department and the Federal Trade Commission was “extremely
unfortunate.”
“The commission has demonstrated unreasonable skepticism toward
collaboration by health care providers,” Mr. Balto said.
The antitrust division of the department, under Christine A. Varney,
an assistant attorney general, is widely seen by hospitals as more
sympathetic to their efforts to band together with doctors and
negotiate jointly with health insurance plans.
Officials of the two agencies, which normally share responsibility for
enforcing antitrust laws, are trying to devise a joint statement
explaining how they will evaluate proposed collaborations by doctors
and hospitals. The agencies said, in response to questions, that their
goal was to have one consistent policy, but they refused to give
details of their talks.
The new health care law encourages joint ventures, known as
accountable care organizations, in which doctors and hospitals take
collective responsibility for the care of Medicare beneficiaries.
“The creation and operation of accountable care organizations
potentially conflict with the antitrust laws,” Mr. Rosch wrote. “The
Supreme Court long ago prohibited competing providers from jointly
contracting to provide their services, except in specified
circumstances.”
Mr. Rosch, an antitrust lawyer for more than 35 years, said he was
speaking only for himself. But his views on antitrust policy in the
health care industry generally reflect the views of the commission’s
nonpartisan professional staff, based on numerous advisory opinions
issued to health care providers over the last 15 years.
Unless doctors and hospitals share some degree of financial risk, Mr.
Rosch said, the new entities are unlikely to achieve the promised cost
savings. In recent years, independent doctors and hospitals have often
come together to coordinate care but have been reluctant to pool
resources and share the risks of financial losses.
The fragmentation of the health care system, in which patients often
shuttle from doctor to doctor, is widely seen as a major problem.
Under the new health care law, doctors and hospitals can earn
financial rewards if they improve the care of Medicare patients while
holding costs below benchmarks set by the federal government.
Dr. Donald M. Berwick, the administrator of the Centers for Medicare
and Medicaid Services, said he would soon issue rules for these groups
of health care providers. If a group becomes so powerful in a market
that it can raise prices without fear of losing business to rivals, it
could be required to seek review from one of the antitrust agencies,
administration officials said. The health care law does not displace
the antitrust laws or provide any exemption for the new entities.
Mr. Rosch said the government must set clear goals for Medicare
savings and measure the performance of accountable care organizations
with respect to both Medicare and the private insurance market.
“Otherwise,” Mr. Rosch said, “there will be a real risk that the
savings accruing to Medicare will just come at the expense of private
insurers.” In other words, he suggested, a network of doctors and
hospitals could offset a loss of Medicare revenue by charging more to
privately insured patients.
In recent years, the Federal Trade Commission has taken the lead in
analyzing joint ventures by health care providers. Citing this
experience, Mr. Rosch said his agency should also be responsible for
policing compliance with the antitrust laws by accountable care
organizations. This approach, he said, would “avoid time-consuming
turf battles” with the Justice Department.
Health care providers said Mr. Rosch and the Federal Trade Commission
were making a power grab that could jeopardize the success of
accountable care organizations. As part of the Obama administration,
they said, Ms. Varney and the Justice Department have a bigger stake
in the success of the new entities.
As a member of the commission in 1996, Ms. Varney said the government
should be receptive to new types of collaboration among health care
providers, a view she has voiced lately as assistant attorney general.
In 2003, as a lawyer in private practice, she testified “on behalf of
the American Hospital Association,” one of her clients, at a hearing
held by the Justice Department and the commission.
In discussions between the two agencies, Mr. Rosch said, the
department has taken the position that health care providers should be
free to choose which agency would review their plans. Such an
arrangement, he said, could lead to “a lack of regulatory
consistency,” with the two agencies applying different standards.
Justice Department officials declined to comment.
Mr. Balto, a senior fellow at the Center for American Progress, a
liberal research and advocacy group, said: “The standards applied by
the F.T.C. are out of date. For health care providers to get approval
from the commission for a joint venture or other form of collaboration
is an exhaustive, expensive process that typically takes more than a
year.”
But another antitrust lawyer in Washington, Katherine I. Funk, said,
“The commission has more experience and expertise analyzing the
clinical integration of health care providers — a key goal of
accountable organizations.”
KMDickson